Ms. Hagan formerly served as the Managing Director of the Coulter Translational Partnership Fund (CTPF), an evergreen fund providing $1.5M a year for investments at both Emory University/Georgia Tech and previously at the University of Washington. Beyond providing capital, she evolved the Coulter Fund into a team-based approach that provided a rich resource for advancing translational projects to clinical adoption.

Ms Hagan managed, conceived and implemented investment processes and procedures that brought business discipline to academic environments. She served as interim management on all investments. She actively participated with innovators and co-investors on operational, funding, growth and exit strategies culminating in the formation of more than 72 start-up companies, twenty-three (38) of which raised over $200M in total funding and introduced new products to the market. Ten (12) products were licensed directly to established medical device companies.

Ms. Hagan has provided expert advice on medical technology investment to early-stage funds and angel investors, including Keiretsu Forum Northwest, Wings, Seraph Capital Network, Johns Hopkins University, Seattle Children’s Hospital, Imperial College London, and University of Calgary. Ms. Hagan has an M.Sc. in Medical Regulatory Affairs and was a lecturer at the University of Washington’s School of Pharmacy Master program for Medical Regulatory Affairs. She has advised, coached, and collaborate with numerous entrepreneurs to develop business models, identify and pitch to potential investors, structure funding, and grow the resulting emerging businesses.

Dr Klein is a member of the Editorial Board of the American Journal of Physiology, and is the Associate Editor of Renal Frontiers in Physiology. Among her honors, she has been an invited speaker at the Nephrogenic Diabetes Insipidus Foundation 2008 Global Conference and the 2015 United States National Institutes (NIH) of Health Renal Pathophysiology Workshop. She is a grant reviewer for the American Heart Association, United States Veterans Administration, NIH and National Kidney Research Fund of the United Kingdom. Her society memberships include American Society of Nephrology, the American Physiological Society and the American Heart Association where she has chaired or co-chaired several committees. Dr. Klein is a frequent reviewer for the Journal of the American Society of Nephrology, the Journal of Biological Chemistry, European Journal of Pharmacology and The American Journal of Physiology Heart, Integrative Physiology and Cell journals.

Dr. Klein received her B.S. in Biochemistry from the University of Scranton and M.S. and Ph.D. in Chemistry from New Mexico State University with a major in Biochemistry and a minor in Analytical Chemistry. She has held postdoctoral positions at the Terre Haute Center for Medical Education, the American Red Cross, and at Emory University working with Dr. Lawrence Philips in the Division of Endocrinology.

Dr. Klein is the author on a total of over one hundred peer reviewed papers, review articles and book chapters. She is a co-inventor on two pending patents.

Dennis Rose has over 30 years of operations and management experience. Early in his career he worked for numerous organizations in Healthcare Information Systems integrations, technology deployments and full systems implementations, followed by managing large healthcare related program deployments across multiple technology endpoints. 

Additionally, Mr. Rose has been involved in consulting and leadership roles with entrepreneurs in early-stage technology and program development improving innovation, understanding value and assessing commercial viability to meet unmet market needs.  Dennis maintains current Project Management and Agile certifications as well as certifications in Service Management ITIL.

Josh Knackert facilitates collaboration and translation between science and business.  He is informed by past experiences as a life sciences researcher, biotechnology commercialization consultant, and medical affairs professional.  He has worked with a variety of organizations in the health science and biotechnology sectors.  He has contributed to companies at various stages of growth, from an early microscopy startup to a large medical device company. Josh has served as a mentor and advisor for numerous entrepreneurs and startups. 

Josh received a M.S. in Cellular and Molecular Pathology and a B.S. in Microbiology, both from the University of Wisconsin-Madison.  Josh is also an X-linked Nephrogenic Diabetes Insipidus (NDI) patient who strives to bring both the rare disease and NDI patient and caregiver perspective to everything he does. 

Ram Pillarisetti, Ph.D.